A new study shows that real-time, continuous glucose monitoring is effective in improving blood glucose control in people with Type 2 diabetes by evaluating Dexcom's (San Diego) Seven CGM device against more traditional methods. Results were published in the online journal, Diabetes Care.
Covidien (Mansfield, Massachusetts) reported an agreement to acquire Barrx Medical (Sunnyvale, California) for $325 million. Barrx Medical is a firm that specializes in the treatment of Barrett's esophagus syndrome using bipolar radio frequency (RF) ablation devices.
Medtronic (Minneapolis) reported FDA approval of its AdaptiveStim with RestoreSensor neurostimulation system, a chronic pain treatment that harnesses motion sensor technology found in smart phones and computer gaming systems to provide effective pain relief and convenience by automatically adapting stimulation levels to the needs of people with chronic back and/or leg pain.
The Berlin Heart Group (Woodlands, Texas/Berlin) unveiled clinical trial data presented yesterday at the "Scientific Sessions 2011" annual meeting of the American Heart Association (AHA; Washington).
